Key Points

• Vaccination coverage among infants subject to the mandatory vaccination requirements in effect since 2018 is relatively high for vaccinations against diphtheria, tetanus, polio, pertussis, Haemophilus influenzae type b, hepatitis B, pneumococcal disease, and meningococcal disease C; however, coverage remains insufficient for the measles, mumps, and rubella (MMR) vaccine, with coverage of 75% in Guadeloupe and 73.1% in Martinique for the second dose of this vaccine. Given the current circulation of the measles virus, only a two-dose vaccination coverage of at least 95% is likely to interrupt transmission of the virus.

• In Guadeloupe and Martinique, 54.7% and 59.8% of infants born in 2023, respectively, received at least one dose of the meningococcal B vaccine, representing increases of 28.3 percentage points and 35.9 percentage points, respectively, compared to the previous year.

• In Guadeloupe and Martinique, 4.1% and 8.0% of infants born in 2023, respectively, received at least one dose of the rotavirus vaccine. In mainland France, significant regional disparities are observed for this vaccination, which has been recommended since 2023.

• Although meningococcal C vaccination coverage has increased by 5.1 percentage points among adolescents in Guadeloupe and Martinique, catch-up vaccination remains very insufficient among young people aged 15 to 19, with vaccination coverage of 53% in Guadeloupe and 39.1% in Martinique, respectively.

• In Guadeloupe, 31.5% of 15-year-old girls and 6.8% of 15-year-old boys have started their HPV vaccination series. In Martinique, 21.9% of 15-year-old girls and 6.3% of 15-year-old boys have started their HPV vaccination series. HPV vaccination coverage increased slightly in 2023, with gains of 5 percentage points among girls in Guadeloupe and 4.3 percentage points in Martinique, and coverage more than doubled among boys compared to 2022, although it remains below 7%. HPV vaccination coverage remains far from the 80% target set in the 10-year cancer control strategy for 2030.

• At the conclusion of the first phase of the HPV vaccination campaign in middle schools, as of December 31, 2023, it is estimated that approximately 26% of girls and 14% of boys aged 12 in Guadeloupe, and approximately 18% of girls and 12% of boys aged 12 in Martinique (born in 2011, mostly enrolled in 7th grade) have received at least one dose of the HPV vaccine. These estimates take into account vaccinations administered in middle schools and in the community. In Guadeloupe, increases in vaccination coverage of 8 percentage points among girls and 5 percentage points among boys, and in Martinique of 7 percentage points among girls and 6 percentage points among boys, were observed between the start and end of the first phase of the campaign, although it is not yet possible to specify the gains directly attributable to the campaign.

• Vaccination coverage against influenza, COVID-19, and shingles remains insufficient among at-risk individuals. Influenza vaccination coverage is declining among people with risk factors, with low coverage among those aged 65–74 (11.9% in Guadeloupe and 8.7% in Martinique). COVID-19 vaccination coverage was 2.3% in Guadeloupe and 2.2% in Martinique among those aged 65 and older. Less than 1% of people aged 65–74 are vaccinated against shingles in both regions.